Current Opinion in Urology was launched in 1991. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of urology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Jean de la Rosette
Dr Jean de la Rosette is Professor in Urology at Amsterdam UMC University Hospital in Amsterdam, the Netherlands, and Professor in Urology at Istanbul Medipol University, Istanbul, Turkey. He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. His main fields of interest are minimal invasive surgery and endourology with a special focus on ablative treatments and urological ultrasound. Dr de la Rosette is a member of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) and the committee on Upper Urinary Tract Urothelial tumors of the ICUD. He is also co-chairman of the committee on Renal Stone Disease of the ICUD. He is past-chairman of the EAU Section of Uro-Technology (ESUT) and board member of the Society of Endourology. Dr de la Rosette was a chairman of the European Association of Urology (EAU) working party on BPH guidelines. Dr de la Rosette has authored or co-authored over 700 peer-reviewed publications and many book chapters. Dr de la Rosette is a member of various urological societies and board member of the Endourological Society and the Société International d’Urologie (SIU). Since 2016 he has held the position of General Secretary of the SIU.
Thomas J. Polascik
Thomas J. Polascik, MD, is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC, USA. Dr Polascik trained at the Brady Urological Institute at the Johns Hopkins Hospital in Baltimore, Maryland, USA. He did an oncology fellowship under the mentorship of Alan W. Partin MD, PhD. He then joined the faculty at Duke University in 1998. His clinical practice and research interests incorporate both prostate and kidney cancer.
In 2006 he developed an interest in the nascent field of focal therapy for prostate cancer. He is the founder and director of the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. The symposium has brought together investigators and clinicians from all regions of the world and the meeting alternates between North America and Europe with co-chairs Drs Jean de la Rosette and Indy Gill. This year marked the tenth annual meeting held in the Netherlands in January 2018 and the next summit will be hosted in Kyoto, Japan, in February 2019.
Dr Polascik is the editor of Imaging and Focal Therapy of Early Prostate Cancer released in 2016. He is the director of the Society of Urologic Oncology fellowship program at Duke and also the Genitourinary Program on Focal Therapy at the Duke Cancer Institute. His research interests include the development of image-guided therapies for early prostate cancer, the development of prostate cancer imaging techniques and minimally invasive treatment options for both prostate and kidney cancer. He has published over 300 manuscripts and book chapters. He has held positions on several boards of directors, advisory boards, and has been active in the North Carolina Urological Association and the Board of Directors with the Southeastern American Urological Association. He is an avid ad hoc reviewer for a number of journals and currently holds a NIH R-O1 and Department of Defense Grant for research.
Ashish M. Kamat
Dr Ashish M. Kamat is a Professor of Urology and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, USA, and a graduate of the AUA Leadership Program.
Dr Kamat specialises in the multidisciplinary management of urologic cancers with an emphasis on bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE.
Dr Kamat is co-President of the International Bladder Cancer Network, Chair of the Bladder Cancer Think Tank (2015), Chair of Bladder Cancer Task Force for SITC, actively participates in various global urologic efforts, and serves on the board of regional and national societies for Urology. He has authored over 200 publications, editorials and book chapters, and has been nominated twice for the Robert M. Chamberlain Distinguished Mentor Award and has been invited as a visiting professor to several universities across the world.
Dr Paolo Gontero is Chairmen of the Division of Urology, San Giovanni Battista Hospital (Molinette), and Associate Professor of Urology at the University of Studies of Torino, Italy.
His main clinical interests are in the field of Surgical Uro-Oncology, devoted to Laparoscopic and Robotic oncological surgery of prostate, kidney and bladder cancers. He has expertize in minimally invasive live donor nephrectomy and reconstructive surgery of transplanted kidney.
He has authored and co-authored more than 250 publications on international journals with his main research interests pertaining to the development of new treatment modalities for non-muscle invasive bladder cancer and prostate cancer. He is Scientific Director of the “Torino Prostate Project”, a multidisciplinary clinical and research working group in the field of prostate cancer and Director of a masters degree in Prostate Oncology. He is involved in international trials and working groups on the development of new diagnostic and therapeutic modalities for prostate cancer and on the assessment of surgery in high risk prostate cancer.
He is chairman of the course on Small Renal Masses at the European School of Urology and holds active membership with EORTC-GU and EMPACT. He has co-authored several book chapters and edited several books, including the latest Problem Based Urology, Springer 2013, awarded by the BMA Book Award as highly commended in surgical specialties and Treating Urothelial Bladder Cancer, Springer 2018. He is a panel member of the European Guidelines for non-muscle invasive bladder cancer and chair of the ICUD on bladder cancer 2017.